Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
74 results:

  • 1. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 2. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An incidental traditional serrated adenoma of the gallbladder: A case report.
    Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
    Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
    Lawler T; Parlato L; Warren Andersen S
    Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary Liver Malignancies".
    Schwantes IR; Mayo SC
    Surgery; 2023 Aug; 174(2):422-424. PubMed ID: 37183133
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of Circulating Tumor DNA in Synchronous Metastatic colorectal cancer at diagnosis Predicts Overall Patient Survival.
    Sayagués JM; Montero JC; Jiménez-Pérez A; Del Carmen S; Rodríguez M; Vidal Tocino R; Montero E; Sanz J; Abad M
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176143
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. European expert panel consensus on the clinical management of BRAF
    Martinelli E; Arnold D; Cervantes A; Stintzing S; Van Cutsem E; Tabernero J; Taieb J; Wasan H; Ciardiello F
    Cancer Treat Rev; 2023 Apr; 115():102541. PubMed ID: 36931147
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis.
    Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
    BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. KRAS, nras, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania.
    Brinzan CS; Aschie M; Cozaru GC; Deacu M; Dumitru E; Burlacu I; Mitroi A
    Medicine (Baltimore); 2022 Oct; 101(40):e30979. PubMed ID: 36221415
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
    Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
    Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicogenomic Characteristics and Treatment of Young-Onset colorectal cancer Patients Treated With Palliative Therapy in Real-World Practice.
    Jeong H; Lee E; Kim D; Kim J; Kim SY; Hong YS; Kim TW; Kim JE
    Cancer Control; 2022; 29():10732748221096842. PubMed ID: 35475677
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Performance of Idylla
    Makutani Y; Sakai K; Yamada M; Wada T; Chikugo T; Satou T; Iwasa Y; Yamamoto H; de Velasco MA; Nishio K; Kawamura J
    Int J Clin Oncol; 2022 Jul; 27(7):1180-1187. PubMed ID: 35474548
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KRAS and nras mutational analysis in plasma ctDNA from patients with metastatic colorectal cancer by real-time PCR and digital PCR.
    Pinheiro M; Peixoto A; Rocha P; Veiga I; Pinto C; Santos C; Pinto P; Guerra J; Escudeiro C; Barbosa A; Silva J; Teixeira MR
    Int J Colorectal Dis; 2022 Apr; 37(4):895-905. PubMed ID: 35303157
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. diagnosis and Treatment of ERBB2-Positive Metastatic colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies.
    Ros J; Saoudi N; Salvà F; Baraibar I; Alonso G; Tabernero J; Elez E
    Expert Opin Investig Drugs; 2022 Mar; 31(3):235-247. PubMed ID: 35133234
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
    Foppa C; Tamburello S; Maroli A; Carvello M; Poliani L; Laghi L; Malesci A; Montorsi M; Perea J; Spinelli A
    Eur J Surg Oncol; 2022 Apr; 48(4):857-863. PubMed ID: 34740480
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Application of ensemble clustering and survival tree analysis for identifying prognostic clinicogenomic features in patients with colorectal cancer from the 100,000 Genomes Project.
    Wei Y; Papachristou N; Mueller S; ; Chang WH; Lai AG
    BMC Res Notes; 2021 Oct; 14(1):385. PubMed ID: 34600575
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
    Fernández Montes A; Carmona-Bayonas A; Jimenez-Fonseca P; Vázquez Rivera F; Martinez Lago N; Covela Rúa M; Cousillas Castiñeiras A; Gonzalez Villarroel P; De la Cámara Gómez J; Méndez JCM; Carriles Fernández C; Sanchez Cánovas M; Garcia García T
    Sci Rep; 2021 Jul; 11(1):14321. PubMed ID: 34253805
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic colorectal cancer.
    Diehl TM; Abbott DE
    Curr Treat Options Oncol; 2021 Jul; 22(9):82. PubMed ID: 34224023
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
    Bocciarelli C; Caumont C; Samaison L; Cariou M; Aline-Fardin A; Doucet L; Roudié J; Terris B; Merlio JP; Marcorelles P; Cappellen D; Uguen A
    Hum Pathol; 2021 Aug; 114():99-109. PubMed ID: 34019865
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.